$VTEX

Gomide de Faria Mariano sold $19K of VTEX (indirect holdings)

Gomide de Faria Mariano (Chief Executive Officer) sold 4,808 indirectly-held shares of VTEX (VTEX) at $4.04 on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gomide de Faria Mariano
Published Jun 30, 2026, 8:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
high confidence
Mentioned
$VTEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

The disclosure provides transparency on CEO selling activity but does not include new operational, financial, or regulatory developments for VTEX.

02

Market read

Traders may note the insider sale for sentiment monitoring, but it is unlikely to drive a standalone repricing.

03

What to watch

The sale is indirect and under a pre-arranged plan, which often reduces interpretability; without additional context (e.g., total insider activity trend), signal is weak.

Relevance 2/10Novelty 3/10Timing: Filed June 30; transaction dated June 29 (10b5-1 insider sale).

Background

The article is an SEC Form 4 insider transaction disclosure for VTEX.

Company-level read

Ticker impact

$VTEXNeutralHigh confidence
Context

SEC Form 4 shows CEO Gomide de Faria Mariano sold 4,808 VTEX shares for about $19.4K under a 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely noise unless paired with other disclosures.

Evidence & confidence

The filing is an open-market sale by the CEO, explicitly under a pre-arranged Rule 10b5-1 plan, with modest dollar value relative to typical market moves.

Market effects

Minimal—this is an individual insider transaction, not a sector/regulatory datapoint.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may still watch for follow-on sales or other negative disclosures.

Key entities

  • VTEX

    Issuer of the SEC Form 4 insider transaction; CEO sold shares under a 10b5-1 plan.

  • Gomide de Faria Mariano

    VTEX CEO who executed an open-market sale of 4,808 shares on 2026-06-29.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a